نتائج البحث - Katja Deterding

تنقيح النتائج
  1. 1
    Direct-Acting Antiviral–Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis C

    Direct-Acting Antiviral–Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis C حسب Julia Hengst, Christine S. Falk, Verena Schlaphoff, Katja Deterding, Michael P. Manns, Markus Cornberg, Heiner Wedemeyer

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Bile acid increase during bulevirtide treatment of hepatitis D is not associated with a decline in <scp>HDV RNA</scp>

    Bile acid increase during bulevirtide treatment of hepatitis D is not associated with a decline in <scp>HDV RNA</scp> حسب Katja Deterding, Cheng‐Jian Xu, Kerstin Port, Christopher Dietz‐Fricke, Xun Jiang, Benjamin Maasoumy, Markus Cornberg, Heiner Wedemeyer

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Clinical long-term outcome of hepatitis D compared to hepatitis B monoinfection

    Clinical long-term outcome of hepatitis D compared to hepatitis B monoinfection حسب A. Wranke, Benjamin Heidrich, Katja Deterding, Katharina Luise Hupa‐Breier, J. Kirschner, Birgit Bremer, Markus Cornberg, Heiner Wedemeyer

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Chronic hepatitis C virus infection irreversibly impacts human natural killer cell repertoire diversity

    Chronic hepatitis C virus infection irreversibly impacts human natural killer cell repertoire diversity حسب Benedikt Strunz, Julia Hengst, Katja Deterding, Michael P. Manns, Markus Cornberg, Hans‐Gustaf Ljunggren, Heiner Wedemeyer, Niklas K. Björkström

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Value and Kinetics of Virological Markers in the Natural Course of Chronic Hepatitis D Virus Infection

    Value and Kinetics of Virological Markers in the Natural Course of Chronic Hepatitis D Virus Infection حسب Lisa Sandmann, Valerie Ohlendorf, Alena Friederike Ehrenbauer, Birgit Bremer, Anke Kraft, Markus Cornberg, Katja Deterding, Heiner Wedemeyer, Benjamin Maasoumy

    منشور في 2025
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Establishment of a Novel Quantitative Hepatitis D Virus (HDV) RNA Assay Using the Cobas TaqMan Platform To Study HDV RNA Kinetics

    Establishment of a Novel Quantitative Hepatitis D Virus (HDV) RNA Assay Using the Cobas TaqMan Platform To Study HDV RNA Kinetics حسب Ingmar Mederacke, Birgit Bremer, Benjamin Heidrich, J. Kirschner, Katja Deterding, C.‐Thomas Bock, Karsten Wursthorn, Michael P. Manns, Heiner Wedemeyer

    منشور في 2010
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Drug–Drug Interactions With Novel All Oral Interferon-Free Antiviral Agents in a Large Real-World Cohort

    Drug–Drug Interactions With Novel All Oral Interferon-Free Antiviral Agents in a Large Real-World Cohort حسب Christoph Höner zu Siederdissen, Benjamin Maasoumy, Fiona Marra, Katja Deterding, Kerstin Port, Michael P. Manns, Markus Cornberg, David Back, Heiner Wedemeyer

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Interferon‐free therapy of chronic hepatitis C with direct‐acting antivirals does not change the short‐term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis

    Interferon‐free therapy of chronic hepatitis C with direct‐acting antivirals does not change the short‐term risk for de novo hepatocellular carcinoma in patients with liver cirrhos... حسب F Mettke, Bernhard Schlevogt, Katja Deterding, A. Wranke, Andrea Smith, Kerstin Port, M P Manns, Arndt Vogel, Markus Cornberg, Heiner Wedemeyer

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Dominance of hepatitis C virus (HCV) is associated with lower quantitative hepatitis B surface antigen and higher serum interferon-γ-induced protein 10 levels in HBV/HCV-coinfected patients

    Dominance of hepatitis C virus (HCV) is associated with lower quantitative hepatitis B surface antigen and higher serum interferon-γ-induced protein 10 levels in HBV/HCV-coinfected... حسب Steffen B. Wiegand, Jerzy Jaroszewicz, Andrej Potthoff, Christoph Höner zu Siederdissen, Benjamin Maasoumy, Katja Deterding, Michael P. Manns, Heiner Wedemeyer, Markus Cornberg

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D

    Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D حسب Benjamin Maasoumy, Steffen B. Wiegand, Jerzy Jaroszewicz, Birgit Bremer, Patrick Lehmann, Katja Deterding, A Taranta, Michael P. Manns, Heiner Wedemeyer, Dieter Glebe, Markus Cornberg

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Nonreversible MAIT cell‐dysfunction in chronic hepatitis C virus infection despite successful interferon‐free therapy

    Nonreversible MAIT cell‐dysfunction in chronic hepatitis C virus infection despite successful interferon‐free therapy حسب Julia Hengst, Benedikt Strunz, Katja Deterding, Hans‐Gustaf Ljunggren, Edwin Leeansyah, Michael P. Manns, Markus Cornberg, Johan K. Sandberg, Heiner Wedemeyer, Niklas K. Björkström

    منشور في 2016
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Development and evaluation of a baseline‐event‐anticipation score for hepatitis delta

    Development and evaluation of a baseline‐event‐anticipation score for hepatitis delta حسب B. Calle Serrano, Anika Großhennig, María Homs, Benjamin Heidrich, Andreas Erhardt, Katja Deterding, Jerzy Jaroszewicz, Birgit Bremer, Armin Koch, Markus Cornberg, Michael P. Manns, Marı́a Buti, Heiner Wedemeyer

    منشور في 2014
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Improvement of liver function parameters in advanced <scp>HCV</scp>‐associated liver cirrhosis by <scp>IFN</scp>‐free antiviral therapies

    Improvement of liver function parameters in advanced <scp>HCV</scp>‐associated liver cirrhosis by <scp>IFN</scp>‐free antiviral therapies حسب Katja Deterding, Christoph Höner zu Siederdissen, Kerstin Port, Philipp Solbach, L. Sollik, J. Kirschner, Carola Mix, J. Cornberg, D. Worzala, Heiko Mix, Michael P. Manns, Markus Cornberg, Heiner Wedemeyer

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Viral and Host Responses After Stopping Long-term Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B

    Viral and Host Responses After Stopping Long-term Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B حسب Christoph Höner zu Siederdissen, Franziska Rinker, Benjamin Maasoumy, Steffen B. Wiegand, Natalie Filmann, Christine S. Falk, Katja Deterding, Kerstin Port, Carola Mix, Michael P. Manns, Eva Herrmann, Heiner Wedemeyer, Anke Kraft, Markus Cornberg

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta

    Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta حسب Mathias Jachs, Lisa Sandmann, Lukas Hartl, Tammo Lambert Tergast, Michael Schwarz, David Bauer, Lorenz Balcar, Alena Friederike Ehrenbauer, Benedikt Hofer, Markus Cornberg, Henrike Lenzen, Katja Deterding, Michael Trauner, Mattias Mandorfer, Heiner Wedemeyer, Thomas Reiberger, Benjamin Maasoumy

    منشور في 2024
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Compromised Function of Natural Killer Cells in Acute and Chronic Viral Hepatitis

    Compromised Function of Natural Killer Cells in Acute and Chronic Viral Hepatitis حسب Sebastian Lunemann, David F. G. Malone, Julia Hengst, Kerstin Port, Jan Grabowski, Katja Deterding, Antoaneta A. Markova, Birgit Bremer, Verena Schlaphoff, Markus Cornberg, Michael P. Manns, Johan K. Sandberg, Hans‐Gustaf Ljunggren, Niklas K. Björkström, Heiner Wedemeyer

    منشور في 2013
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Safety and Effectiveness of Direct-Acting Antiviral Agents for Treatment of Patients With Chronic Hepatitis C Virus Infection and Cirrhosis

    Safety and Effectiveness of Direct-Acting Antiviral Agents for Treatment of Patients With Chronic Hepatitis C Virus Infection and Cirrhosis حسب Raoel Maan, Marjolein van Tilborg, Katja Deterding, Alnoor Ramji, Adriaan J. van der Meer, Florence Wong, Scott Fung, Morris Sherman, Michael P. Manns, Markus Cornberg, Bettina E. Hansen, Heiner Wedemeyer, Harry L.A. Janssen, Robert J. de Knegt, Jordan J. Feld

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis—A real-world case series

    Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis—A real-world case series حسب Christopher Dietz-Fricke, Elisabetta Degasperi, Mathias Jachs, Benjamin Maasoumy, Florian P. Reiter, Andreas Geier, Julia M. Grottenthaler, Christoph P. Berg, Kathrin Sprinzl, Stefan Zeuzem, Juliana Gödiker, Bernhard Schlevogt, Toni Herta, Johannes Wiegand, R. Soffredini, Heiner Wedemeyer, Katja Deterding, Thomas Reiberger, Pietro Lampertico

    منشور في 2024
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Entecavir treatment for chronic hepatitis B: Adaptation is not needed for the majority of naïve patients with a partial virological response

    Entecavir treatment for chronic hepatitis B: Adaptation is not needed for the majority of naïve patients with a partial virological response حسب Roeland Zoutendijk, Jurriën G.P. Reijnders, Ashley Brown, Fabien Zoulim, David Mutimer, Katja Deterding, Jörg Petersen, Wolf Peter Hofmann, Marı́a Buti, Teresa Santantonio, Florian van Bömmel, Pierre Pradat, Ye Htun Oo, Marc Luetgehetmann, Thomas Berg, Bettina E. Hansen, Heiner Wedemeyer, Harry L.A. Janssen

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatment

    Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatment حسب Andreas Erhardt, Katja Deterding, Yves Benhamou, Markus Reiser, Xavier Forns, Stanislas Pol, José Luís Calleja, Susanne Ross, Hans Christian Spangenberg, Javier García‐Samaniego, Michael Fuchs, Jaime Enríquez, Johannes Wiegand, Jerry O. Stern, K. Wu, George Kukolj, Martin Marquis, Pierre L. Beaulieu, Gerhard Nehmiz, Jürgen Steffgen

    منشور في 2009
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: